|
|
|||
Description:Coenzyme Q serves as a redox carrier in the mitochondrial respiratory chain and is a lipid-soluble antioxidant. CoQ10 transfers reducing equivalents from various dehydrogenases to complex III (ubiquinone cytochrome c reductase) and acts as a transmembrane hydrogen carrier. The isoprenoid chain of Q10 varies in length between species and is determined by prenyl diphosphate synthase. Q10 deficiency can be caused by mutations in mitochondrial parahydroxybenzoate-polyprenyltransferase (COQ2), prenyl diphosphate synthase, subunit 1(PDSS1), prenyl diphosphate synthase, subunit 2 (PDSS2), and APTX gene. Both PDSS1 and PDSS2 are required for the generation of prenyl diphosphate synthase. Humans possess a heterotetrameric prenyl diphosphate synthase composed of PDSS1 and PDSS2 gene products that produces Q10. Mutations in PDSS2 gene have been reported causing primary CoQ10 deficiency in an infant with fatal Leigh syndrome and nephrotic syndrome. If there is biochemical evidence of Q10 deficiency or complex III deficiency, DNA analysis of the relevant genes can be performed to confirm the diagnosis. PDSS2 gene maps to chromosome 6q21. It contains 8 exons and encodes for a protein of 399 amino acids. Reasons for Referral:
Testing Methodology:The exons and flanking intronic regions of the PDSS2 gene are PCR amplified and sequenced in both the forward and reverse directions. Specimen Requirements:Blood: EDTA (purple-top)
tubes: Adult: 14
cc; Child: 6 cc; Infant: 2-3 cc Turnaround Time:Index: 4 weeks CPT Codes and Prices:Index: 83891, 83904x16,
83898x8, 83912, 83894x2 Shipping InformationForms:>> Gene
Sequencing Requisition or Mitochondrial
Requisition - Mitochondrial Diagnostic Checklist is included References:1. Lopez LC, Schuelke M, Quinzii CM, et al. Leigh Syndrome with Nephropathy
and CoQ10 Deficiency Due to decaprenyl diphosphate synthase subunit
2 (PDSS2) Mutations. Am. J. Hum. Genet. 2006; 79:1125–1129. Test Codes:Index: 3410 |